Author Correction: DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targets

Authors and Affiliations

1. Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

   Arwa Raies, Ewa Tulodziecka, James Stainer, Lawrence Middleton, Andrew R. Harper, Slavé Petrovski & Dimitrios Vitsios

2. Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA

   Ryan S. Dhindsa

3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA

   Ryan S. Dhindsa

4. Emerging Innovations, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA

   Pamela Hill

5. Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden

   Ola Engkvist

6. Department of Medicine, University of Melbourne, Austin Health, Melbourne, VIC, Australia

   Slavé Petrovski

Corresponding author

Correspondence to Dimitrios Vitsios.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions